Research led by the US National Institutes of Health indicates that Moderna's covid-19 vaccine can protect people against the delta variant and possibly newer variants.
The analysis was done on the blood samples of 24 fully vaccinated volunteers and determined that, after six months, 96% of the samples had a complete antibody response against the delta variant.